{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03934",
    "Peptide Name": "Brevinin-1LTe (B1LTe, natural AMPs, frog, amphibians, animals; XXU; 1S=S, UCSS1a; variants: brevinin-1 analogue 5R)",
    "Source": "skin secretion, the broad-folded frog,Hylarana latouchii",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FLGTVLKVAAKVLPAALCQIFKKC",
    "Sequence Length": 24,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA",
      "Hemolytic",
      "Antibiofilm"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 4,
    "Boman Index": -0.96,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "67%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is highly similar (91.67%) toBrevinin-1LT2L=A=K: 17%; GRAVY: 1.179; M Wt: 2562.259; M formula: C121H205N29O27S2.Activity: active against S. aureus ATCC 6538 or MRSA (MIC 1-2 uM), E. faecalis NCTC \n12697 (MIC 2 uM), E. coli ATCC 8739 (MIC 2 uM), K. pneumoniae ATCC 43816 (MIC 32 uM), P. aeruginosa ATCC 9027 (MIC 16 uM), A. baumannii ATCC BAA 747 (MIC 4 uM). In addition, it's more potent in eradicating biofilms of Gram+ pathogens than Gram-.Antimicrobial robustness: NaCl-insensitive:S. aureus; KCl-insensitive:S. aureus; NH4Cl-insensitive:S. aureus; MgCl2-insensitive:S. aureus; CaCl2-insensitive:S. aureus; FeCl3-insensitive:S. aureus; NaCl-sensitive:E. coli; KCl-insensitive:E. coli; NH4Cl-insensitive:E. coli; MgCl2-insensitive:E. coli; CaCl2-sensitive:E. coli; FeCl3-insensitive:E. coli;Toxicity: human RBC: HC50 6.4 uM, highly hemolytic.SAR: incorporation of D-amino acids and arginine increased peptide cell selectivity.",
    "Author": "Zou W, Sun R, Yao A, Zhou M, Chen X, Ma C, Wang T, Jiang Y, Chen T, Shaw C, Wang L. 2023",
    "Reference": "Comput Struct Biotechnol J. 2023 Nov 19;21:5719-5737. doi: 10.1016/j.csbj.2023.11.031.PubMed",
    "Title": "A promising antibiotic candidate, brevinin-1 analogue 5R, against drug-resistant bacteria, with insights into its membrane-targeting mechanism"
  },
  "3D Structure": []
}